Osteopontin is Critical for Hyperactive mTOR-Induced Tumorigenesis in Oral Squamous Cell Carcinoma

Ning Gan1,2,3,4, Sihai Zou1,2,3, Wenming Hang1,2,3

  • 1Stomatological Hospital of Chongqing Medical University, Chongqing 401147, China.

Journal of Cancer
|June 23, 2017
PubMed

Insights

Osteopontin (OPN) is upregulated in oral squamous cell carcinoma (OSCC) and drives tumor growth. Mechanistic target of rapamycin complex 1 (mTORC1) enhances OPN expression, suggesting both are potential therapeutic targets for OSCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Mechanistic target of rapamycin (mTOR) signaling is implicated in oral squamous cell carcinoma (OSCC) development.
  • The precise molecular mechanisms linking mTOR to OSCC progression are not fully elucidated.

Purpose of the Study:

  • To investigate the role of osteopontin (OPN) in OSCC.
  • To elucidate the relationship between mTOR complex 1 (mTORC1) and OPN expression in OSCC.

Main Methods:

  • Analysis of OPN expression in OSCC tissues and cell lines.
  • Assessment of OPN's effect on OSCC cell proliferation, colony formation, and tumorigenicity.
  • Correlation analysis between mTORC1 activity and OPN levels.
  • Investigation of the regulatory pathway involving mTORC1, ERRα, and OPN.

Main Results:

  • Osteopontin (OPN) expression was significantly increased in OSCC tissues and cell lines.
  • Reduced OPN levels inhibited OSCC cell proliferation, colony formation, and in vivo tumor growth.
  • A positive correlation was observed between mTORC1 activity and OPN expression in OSCC.
  • mTORC1 was found to enhance OPN expression via up-regulation of ERRα.

Conclusions:

  • OPN is a critical downstream target of mTORC1 and plays a crucial role in OSCC development.
  • mTORC1, ERRα, and OPN represent potential therapeutic targets for OSCC treatment, particularly in cases with aberrant mTORC1 signaling.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K